Karin Bowen - Late-Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 31 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in COPD: A Post-hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)

Dave Singh, Fernando J Martinez,John R Hurst, MeiLan K Han, Chris P Gale, Martin Fredriksson, Dobrawa Kisielewicz, Alec Mushunje,Charlotta Movitz, Nikki Ojili,Himanshu Parikh,Niki Arya,Karin Bowen,Mehul Patel

American Journal of Respiratory and Critical Care Medicine (2024)

引用0浏览0WOS引用

Benefits of Budesonide/glycopyrronium/formoterol Fumarate Dihydrate on Lung Function and Exacerbations of COPD: a Post-Hoc Analysis of the KRONOS Study by Blood Eosinophil Level and Exacerbation History

Shigeo Muro,Tomotaka Kawayama,Hisatoshi Sugiura, Munehiro Seki, Elizabeth A. Duncan,Karin Bowen,Jonathan Marshall,Ayman Megally,Mehul Patel

RESPIRATORY RESEARCHno. 1 (2024)

引用0浏览0WOS引用

VJBM-2023-0014 Final

Jonathan Corren,Michael Wechsler,Gene Colice,Karin Bowen,Andrew Menzies-Gow,Elliot Israel,Janet Griffiths,Gun Almqvist,Sandhia Ponnarambil,Christopher Brightling,Arnaud Bourdin

Video journal of biomedicine (2024)

引用0浏览0引用

Step Up to ICS/LAMA/LABA Vs Switch to LAMA/LABA in Patients with COPD on ICS/LABA: Post Hoc Analysis of KRONOS

Dave Singh,Mona Bafadhel,Karin Bowen,Niki Arya,Jonathan Marshall,Himanshu Parikh,Mehul Patel

EUROPEAN RESPIRATORY JOURNAL (2023)

引用0浏览0引用

Mortality Risk Reduction with Budesonide/glycopyrrolate/formoterol Fumarate Versus Fluticasone Furoate/umeclidinium/vilanterol in COPD: a Matching-Adjusted Indirect Comparison Based on ETHOS and IMPACT

Daiana Stolz,Erik Hermansson,Mario Ouwens,Barinder Singh, Akanksha Sharma,Dan Jackson,Patrick Darken,Jonathan Marshall,Karin Bowen,Hana Muellerova,Bernardino Alcazar Navarrete,Richard Russell,MeiLan K. Han, Deniz Tansey-Dwyer

B22 NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1（2023）

引用1浏览0WOS引用

Tezepelumab for the Treatment of Severe Asthma: a Plain Language Summary of the PATHWAY and NAVIGATOR Studies

Jonathan Corren,Andrew Menzies‐Gow,Johan Bimmel, Anthony McGuinness,Gun Almqvist,Karin Bowen, José-Marie Griffiths,Sandhia Ponnarambil,Arnaud Bourdin,Elliot Israel,Gene Colice,Christopher E. Brightling,Michael E. Wechsler

Immunotherapyno. 16 (2023): 1327-1340

引用0浏览0引用

Effet Du Tezepelumab Chez Les Patients Ayant Un Asthme Allergique : Résultats De L’étude De Phase IIb PATHWAY

J. Corren,G. Colice,K. Salapa,K. Bowen,J.P. Llanos-Ackert,G. Thabut

Revue des maladies respiratoires actualités（2021）

引用0浏览0引用

Tezepelumab Efficacy in Patients with Allergic and Non-Allergic Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study

Jonathan Corren,Gene Colice,Kinga Salapa,Karin Bowen,Jean-Pierre Llanos-Ackert

The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The jo...（2021）

引用0浏览0引用

Efficacy of Tezepelumab in Patients with Low and High Bronchodilator Reversibility in PATHWAY

Jonathan Corren,Mark C. Liu,Karin Bowen,Kinga Salapa,Gene Colice,Jean-Pierre Llanos-Ackert

Pneumologie（2021）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn